tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Taylor, 127 are a BUY (60.48%), 65 are a HOLD (30.95%), 18 are a SELL (8.57%).
Analyst Matthew Taylor, currently employed at JEFFERIES, carries an average stock price target met ratio of 68.67% that have a potential upside of 17.5% achieved within 171 days.
Matthew Taylor’s has documented 398 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 18-Jul-2025.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/27/2018. The price target of $36 was fulfilled within 2 days with a profit of $2.71 (8.14%) receiving and performance score of 40.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$145
$18.81 (14.91%)
$137
21 days ago
(18-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
365
Hold
$135
$8.81 (6.98%)
$140
21 days ago
(18-Jul-2025)
5/7 (71.43%)
$11.33 (9.16%)
122
Buy
$145
$18.81 (14.91%)
$139
21 days ago
(18-Jul-2025)
8/9 (88.89%)
$21.33 (17.25%)
759
Buy
$145
$18.81 (14.91%)
$124
1 months ago
(08-Jul-2025)
7/8 (87.5%)
$11.64 (8.73%)
316
Buy
$145
$18.81 (14.91%)
$133
3 months 22 days ago
(17-Apr-2025)
2/3 (66.67%)
$14.02 (10.70%)
133
Which stock is Matthew Taylor is most bullish on?
Which stock is Matthew Taylor is most reserved on?
What Year was the first public recommendation made by Matthew Taylor?
